Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 34 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 9737512

    Methods and compositions for treating chronic pain

    The Board of Regents of the University of Texas System · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  2. US 9730954

    miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers

    The Board of Regents of the University of Texas System · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  3. US 9732114

    Compounds having anti-adhesive effects on cancer cells

    The Board of Regents of the University of Texas System · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  4. US 9730894

    Stabilized HME composition with small drug particles

    The Board of Regents of the University of Texas System · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  5. US 9731023

    Somatostatin receptor-based cancer therapy

    The Board of Regents of the University of Texas System · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  6. US 9724344

    Enhanced delivery of drug compositions to treat life threatening infections

    The Board of Regents of the University of Texas System · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  7. US 9725460

    Oridonin analogs, compositions, and methods related thereto

    The Board of Regents of the University of Texas System · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  8. US 9725520

    HER3 specific monoclonal antibodies for diagnostic and therapeutic use

    The Board of Regents of the University of Texas System · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  9. US 9719086

    Micro-RNA family that modulates fibrosis and uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 1, 2017 · Expires Jul 27, 2037

    granted
  10. US 9719088

    Micro-RNA family that modulates fibrosis and uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 1, 2017 · Expires Jul 27, 2037

    granted
  11. US 9719087

    Micro-RNA family that modulates fibrosis and uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 1, 2017 · Expires Jul 27, 2037

    granted
  12. US 9701758

    Anti-CD19 scFv (FMC63) polypeptide

    The Board of Regents of the University of Texas System · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted
  13. US 9701676

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted
  14. US 9695223

    Engineered xylose transporters with reduced glucose inhibition

    The Board of Regents of the University of Texas System · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted
  15. US 9695246

    Anti-OX40 antibodies and methods of using the same

    The Board of Regents of the University of Texas System · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted
  16. US 9687551

    Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity

    The Board of Regents of the University of Texas System · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted
  17. US 9675615

    2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections

    The Board of Regents of the University of Texas System · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  18. US 9675550

    Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine

    The Board of Regents of the University of Texas System · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  19. US 9675544

    Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief

    The Board of Regents of the University of Texas System · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  20. US 9675633

    miRNA for treating cancer and for use with adoptive immunotherapies

    The Board of Regents of the University of Texas System · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  21. US 9675663

    TUSC2 therapies

    The Board of Regents of the University of Texas System · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  22. US 9669016

    Antiparasitic effect of Bis[3,5-Bis(Benzylidene)-4-Oxo-1-Piperidinyl]amide Derivatives

    The Board of Regents of the University of Texas System · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  23. US 9670254

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  24. US 9663504

    Salts of heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted May 30, 2017 · Expires May 25, 2037

    granted